ADCOCK INGRAM HOLDINGS LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.69 ZAR | +0.34% |
|
+1.25% | -7.34% |
| Feb. 21 | Adcock Ingram Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
| Feb. 21 | Transcript : Adcock Ingram Holdings Limited, H1 2024 Earnings Call, Feb 21, 2024 |
ETFs positioned on Adcock Ingram Holdings Limited
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 4 M€ | -4.41% | - | |
| 0.00% | 117 M€ | +1.11% | - | |
| 0.00% | 34 M€ | +2.14% | - |
Adcock Ingram Holdings Limited is one of South Africa's largest pharmaceutical groups. The group also provides hospital products. Net sales break down by family of products as follows:
- pharmaceutical products (79.2%): OTC medicines, prescription products, etc.;
- hospital products (20.8%; No. 1 in South Africa).
At the end of June 2023, the group had 3 production sites located in South Africa.
France accounts for 98.6% of net sales.
Sector
Pharmaceuticals
Calendar
2024-08-20
- Q4 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
55.69
ZAR
Average target price
56
ZAR
Spread / Average Target
+0.56%
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -7.34% | 447M | |
| +19.62% | 43.34B | |
| +20.44% | 21.96B | |
| +10.86% | 14.09B | |
| +13.07% | 13.64B | |
| +37.46% | 11.43B | |
| -8.59% | 6.86B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +8.46% | 5.22B |
- Stock Market
- Equities
- AIP Stock
- Funds and ETFs Adcock Ingram Holdings Limited
